The deletion of DsbA-L could impair mitochondrial functions and active the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling pathway, exacerbating inflammation and insulin resistance (Bai et al. 2020; Oduro et al. 2022). This evidence concerns the gene CGAS and Insulin resistance.